Low frequency of p53 gene mutation and protein expression in mucinous colorectal carcinomas

Cancer Letters

Volumn 103, Issue 2, 1996, Pages 163-170

  Hanski, Christoph ^a   Tiecke, Frank ^a   Hummel, Michael ^a   Hanski, Marie Luise ^a   Ogorek, Dieter ^a   Rolfs, Arndt ^a   Schmitt Gräff, Anette ^a   Stein, Harald ^a   Riecken, Ernst Otto ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

CM 1 antibody; MDM 2 protein; Mucinous colonic carcinoma; p53 mutations; p53 overexpression

Indexed keywords

AVIDIN; BIOTIN; DNA; PROTEIN P53;

ARTICLE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; GENE AMPLIFICATION; GENE FREQUENCY; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; MUCINOUS CARCINOMA; MUTATION RATE; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

EID: 0029963908     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04208-5     Document Type: Article

References (45)

1. Baas, I.O., Mulder, J.W.R., Offerhaus, G.J.A., Vogelstein, B. and Hamilton, S.R. (1994) An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J. Pathol., 172, 5-12.
2. Bell, S.M., Kelly, S.A., Hoyle, J.A., Lewis. F.A., Taylor, G.R., Thompson, H., Dixon, M.F. and Quirke, P. (1991) c-Ki-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis. Br. J. Cancer, 64, 174-178.
3. Bodner, S.M., Minna, J.D., Jensen, S.M., DÀmico, D., Carbone, D., Mitsudomi, T., Fedorko, J., Buchagen, D.L., Nau, M.M., Gazdar, A.F. and Linnoila, R.I. (1992) Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. Oncogene, 7, 743-749.
4. Campo, E., de la Calle-Martin, O., Miguel, R., Palacin, A., Romero, M., Fabregat, V., Vives, J., Cardesa, A. and Yague, J. (1991) Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas. Cancer Res., 51, 4436-4442.
5. Chang, F., Syrjänen, S., Tervahauta, A. and Syrjänen, K. (1993) Tumourigenesis associated with the p53 tumour suppressor gene. Br. J. Cancer, 68, 653-661.
6. Chaubert, P., Benhattar, J., Saraga, E. and Costa, J. (1994) K-ras mutations and p53 alterations in neoplastic and non-neoplastic lesions associated with longstanding ulceratice colitis. Am. J. Pathol., 14, 767-775.
7. Costa, A., Marasca, R., Valentinis, B., Savarino, M., Faranda, A., Silvestrini, R. and Torelli, G. (1995) p53 gene point mutations in relation to p53 nuclear protein accumulation in colorectal cancers. J. Pathol., 176, 45-53.
8. Cripps, K.J., Purdie, C.A., Carder, P.J., White, S., Komine, K., Bird, C.C. and Wyllie, A.H. (1994) A study of stabilisation of p53 protein versus point mutation in colorectal carcinoma. Oncogene, 9, 2739-2743.
9. Dix, B., Robbins, P., Carrello, S., House, A. and Iacopetta, B. (1994) Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas. Br. J. Cancer, 70, 585-590.
10. Domagala, W., Harezga, B., Szadowska, A., Markiewski, M., Weber, K. and Osborn, M. (1993) Nuclear p53 protein accumulates preferentially in medullary and high-grade ductal but rarely in lobular breast carcinomas. Am. J. Pathol., 142, 669-674.
11. Greenblatt, M.S., Bennett, W.P., Hollstein, M. and Harris, C.C. (1994) Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878.
12. Hall, P.A. and Lane, D.P. (1994) p53 in tumour pathology: can we trust immunohistochemistry? - Revisited! J. Pathol., 172, 1-4.
13. Hamelin, R., Laurent-Puig, P., Olschwang, S., Jego, N., Asselain, B., Remvikos, Y., Girodet, J., Salmon, R.J. and Thomas, G. (1994) Association of p53 mutations with short survival in colorectal cancer. Gastroenterology, 106, 42-48.
14. Hanski, C., Bornhoeft, G., Shimoda, T., Hanski, M.L., Lane, D., Stein, H. and Riecken, E.O. (1992) Expression of p53 protein in invasive colorectal carcinomas of different histological type. Cancer, 70, 2772-2777.
15. Hanski, C. (1995) Is mucinous carcinoma of the colorectum a distinct genetic entity? A review. Br. J. Cancer, 72, 1350-1356.
16. Harpaz, N., Peck, A.L., Yin, J., Fiel, I., Hontanosas, M., Tong, T.R., Laurin, J.N., Abraham, J.M., Greenwald, B.D. and Meltzer, S.J. (1994) p53 Protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma. Hum. Pathol., 25, 1069-1074.
17. Hoppe-Seyler, F. and Butz, K. (1993) Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human papillomavirus type 16 E6, human mdm-2, and mutant p53. J. Virol., 67, 3111-3117.
18. Hoshi, T., Imai, M. and Ogawa, K. (1994) Frequent K-ras mutations and absence of p53 mutations in mucin-producing tumors of the pancreas. J. Surg. Oncol., 55, 84-91.
19. Jass, J.R. and Sobm, L.H. (1990) Histological Typing of Intestinal Tumors. Springer Verlag, Berlin.
20. Kennedy, S.M., MacGeogh, C., Jaffe, R. and Spurr, N.K. (1994) Overexpression of the oncoprotein p53 in primary hepatic tumors of childhood does not correlate with gene mutations. Hum. Pathol., 25, 438-442.
21. Ladanyi, M., Cha, C., Lewis, R., Jhanwar, S.C., Huvos, A.G. and Healey, J.H. (1993) MDM2 gene amplification in metastatic osteosarcoma. Cancer Res., 53, 16-18.
22. Lane, D.P. (1994) The regulation of p53 function: Steiner award lecture. Int. J. Cancer, 57, 623-627.
23. Leach, F.S., Tokino, T., Meltzer, P., Burrell, M., Oliner, J.D., Smith, S., Hill, D.E., Sidransky, D., Kinzler, K.W. and Vogelstein, B. (1993) p53 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res., 53, 2231-2234.
24. Lee, J.M., Abrahamson, J.L.A. and Bernstein, A. (1994) DNA damage, oncogenesis and the p53 tumour-suppressor gene. Mutat. Res., 307, 573-581.
25. MacGeoch, C., Barnes, D.M., Newton, J.A., Mohammed, S.A., Hodgson, S.V., Ng, M., Bishop, D.T. and Spurr, N.K. (1993) p53 protein detected by immunohistochemical staining is not always mutant. Dis. Markers, 11, 239-250.
26. Marchetti, A., Buttitta, F., Pellegrini, S., Campani, D., Diella, F., Cecchetti, D., Callahan, R. and Bistocchi, M. (1993) p53 mutations and histological type of invasive breast carcinoma. Cancer Res., 53, 4665-4669.
27. Markowitz, S., Myeroff, L., Cooper, M., Traicoff, J., Kochera, M., Lutterbaugh, J., Swiriduk. M. and Willson, J. (1994) A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes, hut progresses to tumorigenicity and transforming growth factor-beta independence without inactivating the p53 tumor suppressor gene. J. Clin. Invest., 93, 1005-1013.
28. Midgley, C., Fisher, C., Bartek, J., Vojtesek, B., Lane, D. and Barnes, D. (1992) Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli. J. Cell Sci., 101, 183-189.
29. Milner, B.J., Allan, L.A., Eccles, D.M., Kitchener, H.C., Leonard, R.C., Kelly, K.F., Parkin, D.E. and Haites, N.E. (1993) p53 mutation is a common genetic event in ovarian carcinoma. Cancer Res., 53, 2128-2132.
30. Momand, J., Zambetti, G.P., Olson, D.C., George, D. and Levine A.J. (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69, 1237-1245.
31. Mulder, J.W.R., Baas, I.Q., Polak, M.M., Goodman, S.N. and Offerhaus, G.J.A. (1995) Evaluation of p53 protein ex pression as a marker for long term prognosis in colorectal carcinoma. Br. J. Cancer, 71, 1257-1262.
32. Ohue, M., Tomita, N., Monden, T., Fujita, M., Fukunaga, M., Takami, K., Yana, I., Ohnishi, T., Enomoto, T., Inoue, M., Shimano, T. and Mori, T. (1994) A frequent alteration of p53 gene in carcinoma in adenoma of colon. Cancer Res., 54, 4798-4804.
33. Reifenberger, G., Liu, L., Ichimura, K., Schmidt, E.E. and Collins, V.P. (1993) Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res., 53, 2736-2739.
34. Renninson, J., Baker, B.W., McGown, A.T., Murphy, D., Norton, J.D., Fox, B.W. and Crowther, D. (1994) Immunohistochemical detection of mutant p53 protein in epithelial ovarian cancer using polyclonal antibody CMI: correlation with histopathology and clinical features. Br. J. Cancer, 69, 609-612.
35. Rodrigues, N., Rowan, A., Smith, M.E.F., Kerr, I., Bodmer, W., Cannon, J. et al. (1990) p53 mutations in colorectal cancer. Proc. Natl. Acad. Sci. USA, 87, 7555-7559.
36. Shibata, D.K., Arnheim, N. and Martin, W.J. (1988) Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction. J. Exp. Med., 167, 225-230.
37. Soussi, T., Legros, Y., Lubin, R., Ory, K. and Schlichtholz, B. (1994) Multifactorial analysis of p53 alteration in human cancer: a review. Int. J. Cancer, 57, 1-9.
38. Suzuki, H., Harpaz, N., Tarmin, L., Yin, J., Jiang, H.Y., Bell, J.D., Hontanosas, M., Groisman, G.M., Abraham, J.M. and Meltzer, S.J. (1994) Microsatellite instability in ulcerative colitis-associated colorectal dysplasia and cancers. Cancer Res., 54, 4841-4844.
39. Wiethege, T., Voss, B. and Müller, K.M. (1994) Detection of MDM2-proto-oncogene in paraffin embedded human bronchial epithelium. Cancer Res. Clin. Oncol., 120, 252-255.
40. Williams, A., Browne, S., Yeudal, W., Paterson, I., Marshall, C., Lane, D. and Paraskeva, C. (1993) Molecular events including p53 and k-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinoma. Oncogene, 8, 3063-3072.
41. Wu, J.K., Ye, Z. and Darras, B.T. (1993) Frequency of p53 tumor suppressor gene mutations in human primary brain tumors. Neurosurgery, 33, 824-831.
42. Yin, J., Harpaz, N., Tong, Y., Huang, Y., Laurin, J., Greenwald, B.D., Hontanosas, M., Newkirk, C. and Meltzer, S.J. (1993) p53 point mutations in dysplastic and cancerous ulcerative colitis lesions. Gastroenterology, 104, 1633-1639.
43. Zambetti, G.P. and Levine, A.J. (1993) A comparison of the biological activities of wild-type and mutant p53. FASEB J., 7, 855-865.
44. Zauberman, A., Barak, Y., Ragimov, N., Levy, N. and Oren, M. (1993) Sequence-specific DNA binding by p53: identification of target sites and lack of binding to p53 - MDM2 complexes. EMBO J., 12, 2799-2808.
45. Zhang, S.Y., Ruggeri, B., Agarwal, P., Sorling, A.P., Obara, T., Ura, H., Namiki, M. and Klein-Szanto, A.J (1994) Immunohistochemical analysis of p53 expression in human pancreatic carcinomas. Arch. Pathol. Lab. Med., 118, 150-154.